Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey


Kilickap S., Demirci U., Bugdayci F., Tural D., Korkmaz T., Paydas S., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 14 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.1016/j.jtho.2019.08.1166
  • Title of Journal : JOURNAL OF THORACIC ONCOLOGY